Presentation TCT 2024 Novel Technologies in CEP During TAVR: Emboliner, ProTembo, Emblok, Filterex, and Others Presenter: Tamim Nazif October 30, 2024
Presentation TCT 2024 Primary Endpoint Results with the Second-Generation Cephea Transseptal TMVR System in Complex Mitral Valve Disease Presenter: Pradeep Yadav October 29, 2024
Presentation TCT 2024 CEP Technology Landscape and Study Design Presenter: Mathew Williams October 28, 2024
Presentation NY Valves 2024 Evaluation of the Role of SENTINEL CEPD in Reducing the Risk of Stroke From TAVR in Patients With Bicuspid Aortic Valve Stenosis Presenter: Sukhdeep Singh Basra June 06, 2024
Presentation TCT 2023 Point: PROTECTED TAVR – The Case for CEPD Presenter: Axel Linke October 26, 2023
Presentation TVT 2023 The Stroke Issue and When to Consider Cerebral Embolic Protection Devices (CEPD) Presenter: Tamim Nazif June 07, 2023
Presentation Miami Valves 2023 Cephea Implantation in Native Mitral Valve Presenter: Azeem Latib February 04, 2023
Presentation TCT 2022 New and Novel CEP Devices: Differentiating Features Presenter: Giora Weisz September 17, 2022
Presentation TCT 2022 The Journey of CEP from Clean TAVI to PROTECTED TAVR: Lessons Learned Presenter: Axel Linke September 17, 2022
Presentation TVT 2022 Defining My Wish-List for the Ideal CEP Device Presenter: Giora Weisz June 10, 2022
Presentation TVT 2022 The Cephea Trans-septal System: EFS Program Update Presenter: Vinod H. Thourani June 10, 2022
Presentation TCT 2019 Transseptal III: Cephea — Device Description, Results, and Ongoing Studies Presenter: Thomas Modine September 28, 2019
Presentation SIF 2019 Debate Cerebral Embolic Protection: The Data are Compelling and the Costs Manageable Presenter: Saif Anwaruddin March 30, 2019
Presentation TCT 2017 Emerging TMVR 1: Cephea - Device Description, Critical Appraisal, and Development Plans Presenter: Juan F. Granada October 31, 2017
Presentation TCT 2015 Cephea: Novel Design Features and Clinical Updates Presenter: Juan F. Granada October 12, 2015